Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
基本信息
- 批准号:10270657
- 负责人:
- 金额:$ 69.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT ABSTRACT
In order to advance science and discover cures for the myriad of human diseases, a workforce comprised of
diverse and academically strong physician-scientists trained in hypothesis-driven research, rigorous and data-
intensive methods, and evidence-based clinical practice is crucial. This cohort of trainees must have specialized
and focused training that integrates rigorous scientific education with state-of-the-art medical training. The overall
goal of The Ohio State University (OSU) Medical Scientist Training Program (MSTP) is to provide MD-PhD
students with the rigor, depth, and breadth of both scientific and medical education in a way that melds both sets
of training to prepare them to be the future leaders of the biomedical workforce. The expectation is that graduates
of our program will become faculty members at academic, public, or private research enterprises and spend
most of their time conducting research relevant to the improvement of human health. Our program provides the
programmatic structure, curricular content, scientific and clinical guidance, mentoring, facilities, and stimulating
environment to catalyze the integration of research and clinical training essential for a student to become a
successful physician-scientist. We focus on imparting an understanding of the best practices in clinical skills and
research that lead to high clinical acumen, outstanding science that is both rigorous and reproducible, and the
responsible and safe conduct of research and clinical practice. OSU MSTP students will receive a unique blend
of competency-based training from the College of Medicine, the Graduate School, and specific graduate programs
that will synergize to increase the trainees’ ability to translate between the scientific and clinical worlds. As part of
our program, MSTP trainees will receive instruction in technical skills, grant writing, and written and oral
communication that will position them for success in the rapidly advancing academic research field. In addition to
technical training, students in our program receive extensive mentorship throughout their journey from a cohort of
faculty that have received training and embrace this important role. In prior funding periods, students have earned
their degrees in the Biomedical Sciences Graduate Program (BGSP), Neuroscience Graduate Studies Program
(NGSP), or Biomedical Engineering (BME). We now have students receiving PhD training in Public Health (PH)
and anticipate future PhDs across the University in carefully vetted affiliate programs. Because of our curricular
integration and careful oversight by MSTP Leadership, the large majority of our students complete their studies
in 8 years. Although our program has doubled in size in the past 10 years, continued growth of our applicant
pool and our faculty makes continued expansion appropriate, and we plan to increase our class from 10 students
per year to 12. In accordance with NIGMS guidelines, we also request an increase in funding to support 25% of
the students in the program. Our goal for this MSTP is to continue to recruit and train the best and brightest
students, developing future leaders who will enable the Ohio State University Wexner Medical Center to continue
towards its stated mission: To improve people’s lives through innovation in research, education and patient care.
项目摘要
为了推进科学并发现众多人类疾病的治疗方法,劳动力完成了
多样化且在学术上强大的身体科学家接受了假设驱动的研究,严格和数据
密集方法和基于证据的临床实践至关重要。这组学员必须专业
并集中培训,将严格的科学教育与最先进的医学培训相结合。总体
俄亥俄州立大学(OSU)医学科学家培训计划(MSTP)的目标是提供MD-PHD
具有严格的科学和医学教育的严格,深度和广度的学生,以融合两套的方式
培训使他们成为生物医学劳动力的未来领导者。期望毕业生
我们的计划中将成为学术,公共或私人研究企业的教职员工,并花费
他们大部分时间进行与改善人类健康有关的研究。我们的计划提供了
程序化结构,课程内容,科学和临床指导,心理,设施和刺激
催化研究和临床培训的整合的环境使学生成为一个必不可少的环境
成功的身体科学家。我们专注于对临床技能的最佳实践的理解和
导致临床敏锐度高的研究,既严格又可重复的杰出科学,以及
负责和安全的研究和临床实践。 OSU MSTP学生将获得独特的融合
医学院,研究生院和特定研究生课程的基于能力的培训
这将协同作用,以提高培训在科学和临床世界之间转化的能力。作为
我们的计划,MSTP受训人员将获得技术技能,授予写作和书面和口头的指导
沟通将使他们在快速发展的学术研究领域取得成功。此外
技术培训,我们计划中的学生在整个旅程中都有广泛的心态
接受培训并接受这一重要角色的教师。在以前的资助期间,学生赚了
他们在生物医学研究生课程(BGSP)中的学位,神经科学研究生研究计划
(NGSP)或生物医学工程(BME)。现在,我们有学生接受公共卫生博士培训(PH)
并预测全大学的未来博士学位。因为我们的课程
MSTP领导层的整合和仔细的监督,我们的大多数学生都完成了学习
8年。尽管我们的计划在过去10年中的规模增加了一倍,但申请人的持续增长
游泳池和我们的教师使持续的扩展适当,我们计划从10名学生中增加班级
每年至12。根据NIGMS指南,我们还要求增加资金以支持25%
计划中的学生。我们的MSTP目标是继续招募和训练最好,最聪明
学生,发展未来的领导者,他们将使俄亥俄州立大学韦克斯纳医学中心继续
朝着既定的使命:通过研究,教育和患者护理的创新来改善人们的生活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GINNY L BUMGARDNER其他文献
GINNY L BUMGARDNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GINNY L BUMGARDNER', 18)}}的其他基金
CTSA Predoctoral T32 at the Ohio State University
俄亥俄州立大学 CTSA 博士前 T32
- 批准号:
10705448 - 财政年份:2023
- 资助金额:
$ 69.11万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10681215 - 财政年份:2021
- 资助金额:
$ 69.11万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10430249 - 财政年份:2021
- 资助金额:
$ 69.11万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10438948 - 财政年份:2021
- 资助金额:
$ 69.11万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10203783 - 财政年份:2019
- 资助金额:
$ 69.11万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10436921 - 财政年份:2019
- 资助金额:
$ 69.11万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10653007 - 财政年份:2019
- 资助金额:
$ 69.11万 - 项目类别:
Advanced Research Training in Immunology for Surgery Trainees (ARTIST)
外科实习生免疫学高级研究培训 (ARTIST)
- 批准号:
9292218 - 财政年份:2014
- 资助金额:
$ 69.11万 - 项目类别:
相似海外基金
Artificial Intelligence for Dynamic, individualized CPR guidance: AID CPR
人工智能提供动态、个性化的心肺复苏指导:AID CPR
- 批准号:
10644648 - 财政年份:2023
- 资助金额:
$ 69.11万 - 项目类别:
Characterizing the immune infiltrate in muscle-invasive urothelial carcinoma
肌层浸润性尿路上皮癌免疫浸润的特征
- 批准号:
10738992 - 财政年份:2023
- 资助金额:
$ 69.11万 - 项目类别:
29th Annual Midwest Microbial Pathogenesis Conference (MMPC)
第 29 届年度中西部微生物发病机制会议 (MMPC)
- 批准号:
10750604 - 财政年份:2023
- 资助金额:
$ 69.11万 - 项目类别:
Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages to Equity in Health (CLE Health)
北俄亥俄州临床和转化科学合作组织,促进健康公平的联系 (CLE Health)
- 批准号:
10704417 - 财政年份:2023
- 资助金额:
$ 69.11万 - 项目类别:
Novel Immunomodulation and Facilitation of “Suppression Proof” CAR NK cell against Ewing sarcoma
新型免疫调节和促进“抑制证明”CAR NK 细胞对抗尤文肉瘤
- 批准号:
10834579 - 财政年份:2023
- 资助金额:
$ 69.11万 - 项目类别: